| Not Yet Recruiting | Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Trac Biliary Tract Cancer (BTC) | Phase 2 / Phase 3 | 2026-07-01 |
| Not Yet Recruiting | Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Comb Metastatic (Stage IV) Melanoma | Phase 2 | 2026-05-18 |
| Not Yet Recruiting | Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood Colorectal Cancer | Phase 3 | 2026-05-01 |
| Not Yet Recruiting | Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Gen Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer | Phase 3 | 2026-04-01 |
| Not Yet Recruiting | Study Aiming to Test Whether Non-invasive Liquid Biopsies Can Safely Reduce Invasive Surveillance Methods in L Lynch Syndrome | N/A | 2026-04-01 |
| Not Yet Recruiting | Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels Non Small Cell Lung Cancer (Squamous or Non Squamous) | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | Immunotherapy Master Trial for Advanced Cancers Advanced / Metastatic Solid Tumors, Advanced Malignancy | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Cancers, Oropharyngeal Carcinoma | N/A | 2026-04-01 |
| Not Yet Recruiting | Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in Patients With High Risk Colorectal Adenocarcinoma Metastatic in the Liver, Colorectal Cancer | Phase 3 | 2026-03-01 |
| Not Yet Recruiting | Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancers Without Li Metastatic Colorectal Cancer | Phase 2 | 2026-03-01 |
| Recruiting | Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Thei Breast Cancer | N/A | 2026-02-19 |
| Recruiting | Neo-adjuvant Immunotherapy Master Trial for Localized Cancers Localized Cancer | Phase 2 | 2026-01-21 |
| Recruiting | Neo-adjuvant Immunotherapy in Patients With Localized Melanoma Cutaneous Melanoma, Stage III, Mucosal Melanoma | Phase 2 | 2026-01-12 |
| Not Yet Recruiting | Blood Biomarkers Based Screening for HPV-driven OPC Head and Neck Squamous Cell Carcinoma, Anal Cancer, Human Papilloma Virus | N/A | 2026-01-01 |
| Not Yet Recruiting | Antibody-based PET Imaging and Treatment Response in Breast Cancer Treated With an Antibody-drug Conjugate. Locally Advanced or Metastatic Breast Cancer | Phase 2 | 2025-12-31 |
| Recruiting | Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribocic Breast Cancer | Phase 3 | 2025-12-18 |
| Not Yet Recruiting | Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old Locally Advanced Rectal Adenocarcinoma | Phase 3 | 2025-12-15 |
| Recruiting | Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenoc Metastatic Esophageal Adenocarcinoma, Advanced Esophageal Adenocarcinoma, Metastatic Gastric Adenocarcinoma | Phase 2 | 2025-11-20 |
| Recruiting | Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcin Hepatocellular Carcinoma | Phase 2 / Phase 3 | 2025-11-14 |
| Recruiting | Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers Advanced Breast Cancer, Advanced Gastric Cancer, Advanced Urothelial Cancer | Phase 2 | 2025-11-14 |
| Recruiting | Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Non-Small Cell Lung Cancer, Sarcoma, Head &Amp; Neck Cancer | Phase 2 | 2025-10-30 |
| Recruiting | Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients Biliary Tract Cancer | Phase 2 | 2025-10-09 |
| Recruiting | Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy: Impact of Informing Them of AI-predi Unilateral Breast Neoplasms | N/A | 2025-10-07 |
| Not Yet Recruiting | Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an A Triple Negative Breast Neoplasms, Neoplasm Metastasis, HER 2 Low-expressing Breast Cancer | Phase 2 | 2025-10-01 |
| Enrolling By Invitation | Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DX Breast Cancer Metastatic, Breast Cancer Stage IV | Phase 2 | 2025-07-30 |
| Recruiting | Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Breast Cancers, Triple Negative Breast Cancer (TNBC) | Phase 3 | 2025-07-23 |
| Recruiting | Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patie High Risk Prostate Carcinoma, Prostate Cancer | Phase 3 | 2025-04-10 |
| Recruiting | Efficacy of Pemigatinib in Patients With Solid Tumors Characterized by an Alteration of the Gene FGFR in Tumor Solid Tumor, Miscellaneous | Phase 2 | 2025-03-27 |
| Recruiting | Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Me Metastatic Colorectal Cancer, Metastatic Gastroesophageal Adenocarcinoma, DPD Deficiency | Phase 2 | 2025-03-21 |
| Recruiting | Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and S Triple Negative Breast Neoplasms | Phase 2 | 2025-03-11 |
| Recruiting | Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having Leiomyosarcoma Uterus | Phase 2 | 2025-01-27 |
| Recruiting | Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests. Metastatic Breast Cancer, HER2-positive Breast Cancer | Phase 2 | 2025-01-25 |
| Recruiting | Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzy Digestive Cancer, Colorectal Cancer | Phase 2 | 2025-01-20 |
| Recruiting | Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage T Triple-negative Breast Cancer | Phase 2 | 2024-12-27 |
| Recruiting | Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastas Prostatic Cancer, Castration-Resistant | Phase 3 | 2024-10-07 |
| Recruiting | Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders) Prostate Cancer Metastatic | Phase 3 | 2024-09-12 |
| Recruiting | Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Trea Metastatic Triple-Negative Breast Carcinoma | N/A | 2024-07-25 |
| Recruiting | Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI Pancreatic Adenocarcinoma, Ampulla of Vater Carcinoma, Adrenocortical Carcinoma | Phase 2 | 2024-07-23 |
| Recruiting | Personalized Medicine for Advanced Biliary Cancer Patients Biliary Tract Neoplasms | Phase 3 | 2024-07-18 |
| Recruiting | SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Oropharynx Squamous Cell Carcinoma | Phase 2 | 2024-04-03 |
| Recruiting | Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease Leptomeningeal Metastasis, Leptomeningeal Disease, HER2-positive Metastatic Breast Cancer | Phase 2 | 2023-12-18 |
| Active Not Recruiting | Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Breast Cancer Stage IV | Phase 2 | 2023-10-19 |
| Completed | Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions Hepatocellular Carcinoma by BCLC Stage | Phase 2 | 2023-10-12 |
| Recruiting | Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Triple Negative Breast Cancer, Metastatic Breast Cancer | Phase 3 | 2023-10-05 |
| Recruiting | A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer Metastatic Colorectal Cancer, BRAF V600E Mutation Positive | N/A | 2023-07-24 |
| Recruiting | Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With A Gastric Adenocarcinoma, Esophagus Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 | 2023-06-23 |
| Recruiting | Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease Small Cell Lung Carcinoma | Phase 2 | 2023-03-24 |
| Recruiting | Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk Breast Cancer | Phase 2 | 2022-10-12 |
| Active Not Recruiting | Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis Malignant Melanoma, BRAF V600 Mutation, Brain Metastases | Phase 2 | 2022-09-05 |
| Recruiting | TARGETed Therapy Drug MONITOring in DIGestive Oncology Digestive Cancer, Metastatic Colorectal Cancer, Hepatocellular Carcinoma | N/A | 2022-08-29 |
| Recruiting | ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6 Prostate Cancer Metastatic | Phase 3 | 2022-04-19 |
| Recruiting | Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Lung Cancer Metastatic, Renal Cell Carcinoma, Head and Neck Cancer | Phase 3 | 2022-03-08 |
| Active Not Recruiting | Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer Metastatic Breast Cancer With a Isolated Brain Progression | Phase 2 | 2021-12-17 |
| Recruiting | Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Squamous Cell Carcinoma of Head and Neck | Phase 3 | 2021-12-01 |
| Completed | Patient's Choice in the Reduction of Their Treatment in Women Over 65 Year With Breast Cancer Breast Cancer | N/A | 2021-10-01 |
| Recruiting | Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma | Phase 3 | 2021-06-18 |
| Completed | Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPC Oropharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma | N/A | 2021-04-20 |
| Terminated | Evaluation of Bintrafusp Alfa in Operable and Untreated Head and Neck Squamous Cell Carcinoma Squamous Cell Carcinoma of Head and Neck | Phase 2 | 2021-02-04 |
| Terminated | Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2020-11-23 |
| Suspended | Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy. Oxaliplatin-induced Peripheral Neuropathy | Phase 2 | 2020-10-28 |
| Completed | Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locati Squamous Cell Lung Cancer, Vulvar Cancer, Penile Cancer | Phase 2 | 2020-10-28 |
| Active Not Recruiting | Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Pa Oligometastatic Hormone Sensitive Prostate Cancer | Phase 3 | 2020-06-23 |
| Active Not Recruiting | Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer Cancer Metastatic | Phase 3 | 2020-06-11 |
| Completed | COVID-19 Detection Test in Oncology Oncology | — | 2020-05-23 |
| Completed | Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast Canc Breast Neoplasm Female | — | 2020-04-24 |
| Withdrawn | Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Exami Breakthrough Pain | Phase 2 | 2020-02-01 |
| Active Not Recruiting | Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy Prostate Cancer | Phase 3 | 2020-01-09 |
| Active Not Recruiting | Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients Breast Cancer Stage IV, Radiotherapy, Surgery | N/A | 2019-10-23 |
| Completed | Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis Breast Tumors | Phase 2 | 2019-10-21 |
| Active Not Recruiting | Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients. ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status | Phase 2 | 2019-08-26 |
| Completed | Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer Oropharynx Cancer | Phase 2 | 2019-07-25 |
| Active Not Recruiting | My Personalized Breast Screening Breast Screening | N/A | 2019-07-18 |
| Completed | Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adeno Metastatic Pancreatic Adenocarcinoma | Phase 3 | 2019-05-23 |
| Active Not Recruiting | Radiotherapy Omission in Low Risk Ductal in Situ Carcinoma Breast DCIS, Breast Cancer, Low Risk DCIS | N/A | 2019-05-10 |
| Withdrawn | Impact of Immunoscore Colon Test on Adjuvant Therapeutic Strategy in Non-Metastatic Colon Cancer Colonic Neoplasms | N/A | 2019-05-01 |
| Withdrawn | Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiatio Liver Metastases, Colorectal Cancer | N/A | 2019-04-15 |
| Terminated | Regorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal Adenocarcin Adenocarcinoma of the Stomach, Adenocarcinoma of the Gastroesophageal Junction | Phase 1 / Phase 2 | 2019-02-07 |
| Active Not Recruiting | Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Bladder Cancer | Phase 3 | 2019-01-17 |
| Active Not Recruiting | Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy Bladder Cancer | Phase 2 | 2018-12-14 |
| Completed | Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer Esophagus Cancer, Unresectable Malignant Neoplasm | Phase 2 | 2018-12-05 |
| Completed | Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinet Prostate Carcinoma, Castration-resistant Prostate Cancer, Circulating Tumor Cells | Phase 2 | 2018-11-15 |
| Active Not Recruiting | Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients Osteosarcoma | Phase 2 | 2018-10-23 |
| Active Not Recruiting | Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence Local Recurrence of Malignant Tumor of Prostate | N/A | 2018-10-18 |
| Completed | A Patient Consensus for the Research in Supportive Care in French Cancer Care Centers: the CyPRES Project Cancer Patients | — | 2018-10-10 |
| Completed | Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network Colorectal Cancer Metastatic | Phase 2 | 2018-07-25 |
| Active Not Recruiting | Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases Metastatic Breast Cancer, Metastatic Lung Cancer, Metastatic Prostate Cancer | N/A | 2018-07-24 |
| Active Not Recruiting | Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma | N/A | 2018-06-27 |
| Completed | Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours Advanced Solid Tumours, Breast Cancer, Head and Neck Cancer | Phase 1 / Phase 2 | 2018-06-20 |
| Active Not Recruiting | Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer (GETUG-AFU 30) Patients With High-risk MIBC | N/A | 2018-04-19 |
| Terminated | SAFIR-PI3K A Phase II Randomized Maintenance Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy in Breast Cancer, PI3K, Alpelisib | Phase 2 | 2018-03-15 |
| Completed | Study on Androgen Receptor and Triple Negative Breast Cancer Breast Cancer Female, Triple Negative and Androgen Receptor Positive | Phase 2 | 2018-03-14 |
| Active Not Recruiting | PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-Small Cell Carcinoma of Lung, TNM Stage 4 | Phase 3 | 2018-01-24 |
| Recruiting | Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC) Lung Cancer | — | 2017-10-02 |
| Active Not Recruiting | Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes. Hereditary Breast and Ovarian Cancer, Mutation | N/A | 2017-09-21 |
| Active Not Recruiting | QUALIOR Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program Home Based Standardised Adapted Physical Activity Programme, Patients Taking Oral Targeted Therapy for Metastatic Cancer | N/A | 2017-07-11 |
| Completed | Nivolumab in Recurrent and/or Metastatic SCCHN Recurrent and/or Metastatic Platinum-refractory SCCHN | Phase 2 | 2017-07-07 |
| Completed | Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types Sarcoma, Ovarian Neoplasm, Central Nervous System Neoplasm | Phase 2 | 2017-07-05 |
| Completed | Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types Carcinoma, Renal Cell, Head and Neck Neoplasm, Skin Neoplasms | Phase 2 | 2017-06-16 |
| Withdrawn | Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Ea ER-positive Her2-negative Early Breast Cancer | N/A | 2017-05-01 |
| Active Not Recruiting | Tracking Triple-negative Breast Cancer Evolution Through Therapy Triple-Negative Breast Neoplasm | N/A | 2017-04-14 |
| Suspended | Evolution of the Therapeutic Care in Ovarian Cancer From 2011 Ovarian Cancer | — | 2017-04-01 |
| Completed | IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting Colon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2) | Phase 3 | 2017-03-27 |
| Completed | Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck Salivary Gland Carcinoma, Metastatic Cancer, Recurrent Cancer | Phase 2 | 2017-03-24 |
| Completed | PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection Metastatic Breast Cancer | Phase 3 | 2017-03-22 |
| Completed | Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractan Breast Cancer, Estrogen Receptor Positive Tumor, Menopause | Phase 2 | 2017-02-15 |
| Completed | Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER Breast Cancer | Phase 1 | 2017-02-02 |
| Completed | EXPRESS: EXcePtional RESponSe - Exceptional and Unexpected Response to Targeted Therapies Metastatic Cancers | N/A | 2016-12-01 |
| Active Not Recruiting | Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2016-12-01 |
| Active Not Recruiting | Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the P Penile Cancer, Squamous Carcinoma | Phase 2 | 2016-10-17 |
| Completed | Prospective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Pa Breast Cancer | N/A | 2016-09-01 |
| Active Not Recruiting | Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiat Breast Cancer Female | N/A | 2016-09-01 |
| Terminated | Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous C Carcinoma, Squamous Cell of Head and Neck | Phase 1 / Phase 2 | 2016-06-01 |
| Completed | A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signa Metastatic Breast Cancer | Phase 2 | 2016-03-01 |
| Completed | Neoadjuvant Treatment for Advanced Rectal Carcinoma Rectal Carcinoma | Phase 3 | 2016-01-07 |
| Completed | Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Metastatic Renal Cell Carcinoma | Phase 2 | 2016-01-01 |
| Completed | A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma Pancreatic Cancer, Carcinoma | Phase 3 | 2015-10-23 |
| Completed | Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibi Metastatic Breast Cancer | N/A | 2015-05-19 |
| Completed | Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Statu Breast Cancer | Phase 2 | 2015-01-01 |
| Completed | Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined L Neoadjuvant Operable Breast Cancer | Phase 2 | 2015-01-01 |
| Completed | Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU Collecting Duct Carcinoma (Kidney) | Phase 2 | 2014-12-01 |
| Active Not Recruiting | Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterati Solid Tumors, Hematologic Cancers, Metastatic Cancers | Phase 2 | 2014-10-13 |
| Active Not Recruiting | A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas Ewing Sarcomas, Chondrosarcomas, Osteosarcomas | Phase 2 | 2014-09-01 |
| Recruiting | Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 Metastatic Breast Cancer | — | 2014-07-01 |
| Completed | SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients Non-small Cell Lung Cancer Metastatic | Phase 2 | 2014-04-23 |
| Active Not Recruiting | SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breas Metastatic Breast Cancer | Phase 2 | 2014-04-07 |
| Active Not Recruiting | A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Rela Adenocarcinoma of Prostate, Progression of Prostate Cancer | Phase 3 | 2013-12-01 |
| Completed | Treatment After Irinotecan-based Frontline Therapy: Maintenance With Erbitux (in Patients wtRAS mCRC) Metastatic Colorectal Cancer | Phase 2 | 2013-11-22 |
| Active Not Recruiting | A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer Metastatic Prostate Cancer | Phase 3 | 2013-11-13 |
| Completed | Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma Salivary Gland Carcinoma | Phase 2 | 2013-08-26 |
| Completed | Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or R Hematologic Cancers, Solid Tumors, Metastatic Cancer | Phase 2 | 2013-08-01 |
| Completed | Abiraterone Acetate in Molecular Apocrine Breast Cancer Breast Cancer | Phase 2 | 2013-07-01 |
| Active Not Recruiting | Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2 Primary Non-metastatic Breast Cancer, Who Remain Disease-free | Phase 3 | 2013-03-01 |
| Active Not Recruiting | Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy Adenocarcinoma of Prostate | Phase 2 | 2012-12-01 |
| Completed | Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy | Phase 1 / Phase 2 | 2012-12-01 |
| Completed | Dual Targeting of EGFR With Cetuximab and Afatinib to Treat Refractory wtKRAS Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2012-10-01 |
| Completed | Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab Metastatic, Breast Cancer | — | 2012-06-01 |
| Completed | Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenoca Pancreatic Adenocarcinoma (Ductal Adenocarcinoma) | Phase 3 | 2012-04-16 |
| Active Not Recruiting | Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Gen Breast Cancer | Phase 3 | 2012-04-12 |
| Completed | A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Nec Recurrent Head and Neck Cancer, Metastatic Head and Neck Cancer | Phase 2 | 2012-04-01 |
| Recruiting | Chronic Toxicities Related to Treatment in Patients With Localized Cancer Breast Cancer Nos Metastatic Recurrent, Early Lung Cancer | N/A | 2012-02-20 |
| Completed | Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer Cancer of the Rectum | Phase 3 | 2012-01-01 |
| Completed | Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC Patients Carcinoma, Squamous Cell of Head and Neck | Phase 2 | 2012-01-01 |
| Completed | Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patient With Metastatic or Relapsed Uterine Leiomyosarcoma | Phase 2 | 2011-09-01 |
| Active Not Recruiting | Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Metastases | Phase 3 | 2011-07-01 |
| Completed | High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents Metastatic Breast Cancer | — | 2011-05-01 |
| Active Not Recruiting | Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment Ovarian Epithelial Cancer Recurrent | Phase 3 | 2011-04-26 |
| Completed | Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases Colorectal Cancer | Phase 2 | 2011-02-01 |
| Completed | MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 Malignant Neoplasm of Esophagus, Malignant Neoplasm of Stomach | Phase 2 | 2011-01-01 |
| Active Not Recruiting | Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast Canc Breast Cancer, Lumpectomy | N/A | 2010-12-27 |
| Completed | Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer El Prostate Cancer | Phase 2 | 2010-12-09 |
| Completed | Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorect Colorectal Cancer | Phase 2 | 2010-12-01 |
| Completed | Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors Solid Tumors, Metastatic Cancer | Phase 1 | 2010-06-01 |
| Completed | I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutati Infiltrating Urothelial Carcinoma, KRAS Gene Mutation | Phase 3 | 2010-06-01 |
| Completed | Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer. Metastatic Breast Cancer, 70 Years Old Patients and Over, After One Line of Chemotherapy With Trastuzumab | Phase 2 | 2009-12-01 |
| Completed | Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That H Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Liver Cancer | Phase 3 | 2009-07-01 |
| Completed | Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases Breast Cancer, Metastatic Cancer | Phase 2 | 2009-04-01 |
| Terminated | Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Canc Anal Cancer | Phase 2 | 2009-03-01 |
| Completed | Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients Breast Cancer | Phase 2 | 2009-01-01 |
| Active Not Recruiting | Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18) Prostate Cancer | N/A | 2008-10-01 |
| Completed | Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer | Phase 3 | 2008-05-01 |
| Completed | Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage Prostate Cancer | Phase 3 | 2008-04-07 |
| Terminated | Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery Breast Cancer | Phase 2 | 2008-04-01 |
| Completed | Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cance Esophageal Cancer | Phase 2 / Phase 3 | 2008-03-01 |
| Completed | Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surger Colorectal Cancer, Primary Peritoneal Cavity Cancer | Phase 3 | 2008-02-01 |
| Terminated | Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Pa Colorectal Cancer | Phase 2 | 2007-10-29 |
| Completed | Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer Breast Cancer | Phase 2 | 2007-10-01 |
| Completed | Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Can Kidney Cancer | Phase 2 | 2007-09-05 |
| Completed | Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer Breast Cancer | Phase 3 | 2007-09-01 |
| Completed | Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Can Breast Cancer | Phase 1 | 2007-06-01 |
| Active Not Recruiting | Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma Sarcoma | Phase 3 | 2007-03-01 |
| Completed | Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced C Breast Cancer | N/A | 2006-11-01 |
| Completed | Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or R Prostate Cancer | Phase 3 | 2006-10-01 |
| Completed | Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Colorectal Cancer | Phase 2 | 2006-03-23 |
| Completed | Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer Th Breast Cancer, Cognitive/Functional Effects, Depression | Phase 2 | 2006-01-01 |
| Completed | Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery Colorectal Cancer | Phase 3 | 2005-11-08 |
| Completed | Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Sarcoma | Phase 2 | 2005-10-01 |
| Completed | Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2005-06-01 |
| Terminated | Docetaxel in Treating Older Women With Metastatic Breast Cancer Breast Cancer | Phase 2 | 2005-05-01 |
| Completed | Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarc Sarcoma | Phase 2 | 2005-02-01 |
| Completed | Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 2 / Phase 3 | 2004-11-01 |
| Completed | Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer Prostate Cancer | Phase 3 | 2004-10-18 |
| Completed | Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis Desmoid Tumor | Phase 1 / Phase 2 | 2004-09-01 |
| Completed | Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer Breast Cancer | Phase 2 | 2004-07-01 |
| Completed | Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors Extragonadal Germ Cell Tumor, Teratoma, Testicular Germ Cell Tumor | Phase 3 | 2003-11-26 |
| Completed | Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patien Pancreatic Cancer | Phase 2 | 2003-10-06 |
| Completed | Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treati Prostate Cancer | Phase 3 | 2003-09-10 |
| Completed | Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 2003-06-30 |
| Terminated | Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer Stage IB2 Cervical Cancer, Stage II Cervical Cancer, Adenocarcinoma | Phase 3 | 2003-05-01 |
| Completed | Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is L Prostate Cancer | Phase 3 | 2002-11-14 |
| Completed | Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer Kidney Cancer | Phase 2 | 2002-11-04 |
| Terminated | Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer | Phase 3 | 2002-11-01 |
| Completed | Combination Chemotherapy in Treating Women With Stage I Breast Cancer Breast Cancer | Phase 3 | 2002-08-01 |
| Completed | Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer Colorectal Cancer | Phase 2 | 2002-07-23 |
| Completed | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer Breast Cancer | Phase 3 | 2001-06-01 |
| Completed | Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer Inflammatory Breast Cancer | Phase 3 | 2000-10-01 |
| Completed | Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer Prostate Cancer | Phase 3 | 1999-09-01 |
| Completed | Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma Brain and Central Nervous System Tumors | Phase 2 | 1999-07-01 |
| Terminated | Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorecta Colorectal Cancer, Metastatic Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 1999-07-01 |
| Completed | Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver Colorectal Cancer, Metastatic Cancer | Phase 2 | 1999-04-04 |
| Completed | Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tr Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer | Phase 2 | 1999-04-01 |
| Completed | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer Head and Neck Cancer | Phase 2 | 1999-02-01 |
| Completed | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Anal Cancer | Phase 3 | 1999-01-04 |
| Completed | Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Or Head and Neck Cancer | Phase 3 | 1998-10-01 |
| Terminated | Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer Prostate Cancer | Phase 3 | 1998-10-01 |
| Completed | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung C Lung Cancer | Phase 2 | 1998-09-01 |
| Completed | Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer Colorectal Cancer | Phase 3 | 1998-07-22 |
| Terminated | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer | Phase 2 | 1998-03-01 |
| Completed | Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer Kidney Cancer | Phase 2 | 1998-03-01 |
| Completed | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer Prostate Cancer | Phase 3 | 1997-12-01 |
| Terminated | Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer Breast Cancer | N/A | 1997-09-01 |
| Completed | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma Lymphoma | Phase 3 | 1997-02-01 |
| Completed | Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus Esophageal Cancer, Gastric Cancer | Phase 3 | 1996-10-01 |
| Completed | Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer Lung Cancer | Phase 3 | 1996-03-01 |
| Completed | High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Wo Breast Cancer | Phase 3 | 1994-12-01 |
| Completed | Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor | Phase 3 | 1994-02-01 |